New Indications and Dosage Forms for 2003
See also: New Drug Approvals for 2003
Recently Approved
- Inluriyo
Inluriyo (imlunestrant) is an estrogen receptor antagonist indicated for the...
- Forzinity
Forzinity (elamipretide hydrochloride) is a mitochondrial cardiolipin binder...
- Keytruda Qlex
Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) is a programmed...